Status:
COMPLETED
Rapid Test to Detect Staphylococcus Aureus in Blood and Wound Infections
Lead Sponsor:
Michael E. DeBakey VA Medical Center
Collaborating Sponsors:
Baylor College of Medicine
Cepheid
Conditions:
Staphylococcus Aureus
Staphylococcal Skin Infections
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this study is to determine whether the Cepheid GeneXpert system accurately detects Methicillin-Resistant and -Susceptible Staphylococcus aureus in blood cultures and wound swabs.
Detailed Description
Staphylococcus aureus (SA) remains a major pathogen for human beings, causing infections of skin, soft tissue, bone, and other organs. Bacteremia due to this organism is common, and often occurs in as...
Eligibility Criteria
Inclusion
- Positive blood culture with Gram stain revealing Gram positive cocci in clusters
- All wound swabs submitted to the microbiology lab for standard bacteriologic culture may be included.
Exclusion
- Blood cultures that became positive more than 24 hours previously
- Wound swabs for which over 48 hours have passed from the time of collection
Key Trial Info
Start Date :
April 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 1 2010
Estimated Enrollment :
260 Patients enrolled
Trial Details
Trial ID
NCT01198262
Start Date
April 1 2008
End Date
August 1 2010
Last Update
September 10 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Michael E. DeBakey VA Medical Center
Houston, Texas, United States, 77030